KIMS Hospitals reported Q2 FY26 consolidated revenue of **964.9 Cr**, a strong 23.3% YoY growth.

However, EBITDA saw a 6.7% YoY degrowth to **208.2 Cr**, with PAT at **72.0 Cr**, down 40.3% YoY.

This margin compression was partly due to a fair value loss on a call option.

The company's strategy focuses on aggressive expansion and regional market leadership, including doctor partnerships and advanced medical technology.

Recent developments include adding 935 beds across Q1 and Q2 FY26 in key locations like Thane and Bengaluru.

A corrected investor presentation was issued for data point revisions, confirming no impact on financials.

The new 361-bed Bengaluru PES facility begins phased operations this November.

Management highlights plans to add approximately 1361 more beds by Q4 FY27 across Bengaluru, Ongole, Anantapur, Kondapur, and a new Rajahmundry unit, focusing on expanding specialty centers like oncology.